Oppenheimer Asset Management Inc. Has $7.46 Million Position in Humana Inc. (NYSE:HUM)

Oppenheimer Asset Management Inc. raised its position in Humana Inc. (NYSE:HUM) by 18.1% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,957 shares of the insurance provider’s stock after buying an additional 3,057 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Humana were worth $7,457,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Intech Investment Management LLC grew its position in shares of Humana by 46.2% during the 4th quarter. Intech Investment Management LLC now owns 42,287 shares of the insurance provider’s stock worth $19,359,000 after purchasing an additional 13,356 shares in the last quarter. AdvisorShares Investments LLC acquired a new stake in shares of Humana in the 4th quarter valued at $421,000. Sei Investments Co. grew its position in Humana by 0.4% in the first quarter. Sei Investments Co. now owns 61,897 shares of the insurance provider’s stock valued at $21,462,000 after acquiring an additional 264 shares during the last quarter. Cetera Advisors LLC grew its holdings in shares of Humana by 472.1% during the 1st quarter. Cetera Advisors LLC now owns 10,098 shares of the insurance provider’s stock valued at $3,501,000 after purchasing an additional 8,333 shares during the last quarter. Finally, Cetera Investment Advisers lifted its stake in Humana by 249.0% in the 1st quarter. Cetera Investment Advisers now owns 20,945 shares of the insurance provider’s stock valued at $7,262,000 after purchasing an additional 14,944 shares during the last quarter. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

HUM has been the subject of a number of research reports. Royal Bank of Canada increased their price target on Humana from $385.00 to $400.00 and gave the company an “outperform” rating in a research note on Thursday, September 5th. Robert W. Baird began coverage on Humana in a research note on Thursday, May 30th. They set a “neutral” rating and a $374.00 price target on the stock. Baird R W raised Humana to a “hold” rating in a research note on Thursday, May 30th. Cantor Fitzgerald reiterated a “neutral” rating and set a $395.00 target price on shares of Humana in a research report on Tuesday, September 10th. Finally, Piper Sandler started coverage on shares of Humana in a research report on Wednesday, June 26th. They issued an “overweight” rating and a $392.00 price target for the company. Thirteen investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat.com, Humana presently has an average rating of “Hold” and a consensus price target of $398.70.

Humana Trading Down 0.9 %

Shares of HUM stock opened at $321.56 on Monday. The company has a market cap of $38.72 billion, a P/E ratio of 20.02, a PEG ratio of 2.56 and a beta of 0.50. Humana Inc. has a fifty-two week low of $298.61 and a fifty-two week high of $530.54. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.66 and a current ratio of 1.66. The stock has a 50 day simple moving average of $364.11 and a two-hundred day simple moving average of $346.85.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.89 by $1.07. Humana had a net margin of 1.53% and a return on equity of 16.12%. The business had revenue of $29.54 billion for the quarter, compared to analyst estimates of $28.52 billion. During the same period in the prior year, the firm earned $8.94 earnings per share. Humana’s revenue was up 10.4% on a year-over-year basis. Research analysts forecast that Humana Inc. will post 16 earnings per share for the current year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Monday, September 30th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Monday, September 30th. This represents a $3.54 annualized dividend and a yield of 1.10%. Humana’s payout ratio is currently 22.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.